SARAH GORDON: Open Payments
NPI 1528274750 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 61 payments from 17 companies in 2025. Trend: 2023 $903 · 2024 $981 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $375 |
| Novo Nordisk Inc | 17 | $300 |
| Lilly USA, LLC | 5 | $88 |
| GlaxoSmithKline, LLC. | 5 | $77 |
| ABBVIE INC. | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 2 | $39 |
| Intra-Sana Laboratories | 2 | $35 |
| GENZYME CORPORATION | 1 | $28 |
Products named: AIRSUPRA, Ozempic, Wegovy, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, Rybelsus, XIFAXAN.
Industry payments across FL — which companies pay providers there.
